menu
    • menu

    Company profile for Whitehawk Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Whitehawk Therapeutics is a preclinical-stage oncology company leveraging cutting-edge technologies and well-established tumor biology to develop more effective cancer treatments. The company’s innovative three-asset antibody-drug conjugate (ADC) portfolio is designed to address the limitations of earlier-generation ADCs, aiming to make a significant difference for patients facing hard-to-treat cancers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Whitehawk TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2 Headquarters Plaza, East Building, 11th Floor Morristown, NJ 07960
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.whitehawktx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/whitehawk-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Whitehawk Therapeutics Names Margaret Dugan, MD, as CMO
    Whitehawk Therapeutics Names Margaret Dugan, MD, as CMO

    01 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/whitehawk-therapeutics-appoints-margaret-dugan-md-as-chief-medical-officer-302628702.html

    PR NEWSWIRE
    01 Dec 2025
    Share Share
    Whitehawk Therapeutics To Join Piper Sandler Healthcare
    Whitehawk Therapeutics To Join Piper Sandler Healthcare

    26 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference-302626225.html

    PR NEWSWIRE
    26 Nov 2025
    Share Share
    Whitehawk Therapeutics Reveals Q3 Financials & Recent Highlights
    Whitehawk Therapeutics Reveals Q3 Financials & Recent Highlights

    06 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/whitehawk-therapeutics-reports-third-quarter-2025-financial-results-and-recent-highlights-302606356.html

    PR NEWSWIRE
    06 Nov 2025
    Share Share
    Whitehawk Confirms PTK7 as Broadly Expressed Cancer Target
    Whitehawk Confirms PTK7 as Broadly Expressed Cancer Target

    24 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/whitehawk-therapeutics-presents-real-world-analysis-confirming-ptk7-as-a-broadly-expressed-clinically-relevant-target-across-solid-tumors-at-aacr-nci-eortc-302593387.html

    PR NEWSWIRE
    24 Oct 2025
    Share Share
    Tempus, Whitehawk Partner on Biomarker-Based Cancer Research
    Tempus, Whitehawk Partner on Biomarker-Based Cancer Research

    16 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251016398546/en/Tempus-Announces-Collaboration-with-Whitehawk-Therapeutics-to-Advance-Biomarker-Driven-Oncology-Research

    BUSINESSWIRE
    16 Oct 2025
    Share Share
    Whitehawk Therapeutics joins BTIG Virtual Biotech Conference
    Whitehawk Therapeutics joins BTIG Virtual Biotech Conference

    22 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/whitehawk-therapeutics-to-participate-in-the-btig-virtual-biotechnology-conference-302509852.html

    PR NEWSWIRE
    22 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search